Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

SELL
$62.32 - $89.47 $62,756 - $90,096
-1,007 Reduced 7.9%
11,733 $1.01 Million
Q3 2022

Nov 23, 2022

BUY
$59.54 - $68.01 $14,289 - $16,322
240 Added 1.92%
12,740 $821,000
Q2 2022

Aug 11, 2022

BUY
$57.72 - $65.01 $222,914 - $251,068
3,862 Added 44.71%
12,500 $789,000
Q1 2022

May 12, 2022

SELL
$57.92 - $72.58 $463 - $580
-8 Reduced 0.09%
8,638 $533,000
Q4 2021

Feb 25, 2022

BUY
$64.88 - $73.64 $560,952 - $636,691
8,646 New
8,646 $530,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Invst, LLC Portfolio

Follow Invst, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invst, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invst, LLC with notifications on news.